Geneos Wealth Management’s First Trust SMID Capital Strength ETF FSCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-600
Closed -$21.4K 3234
2025
Q2
$21.4K Sell
600
-2,700
-82% -$93.7K ﹤0.01% 1996
2025
Q1
$114K Buy
3,300
+2,200
+200% +$78.1K ﹤0.01% 1501
2024
Q4
$39K Hold
1,100
﹤0.01% 1414
2024
Q3
$38.8K Hold
1,100
﹤0.01% 1288
2024
Q2
$35.3K Hold
1,100
﹤0.01% 1185
2024
Q1
$36.4K Hold
1,100
﹤0.01% 1178
2023
Q4
$34.3K Hold
1,100
﹤0.01% 1187
2023
Q3
$30.3K Buy
1,100
+100
+10% +$2.88K ﹤0.01% 1229
2023
Q2
$28.8K Hold
1,000
﹤0.01% 1257
2023
Q1
$27.6K Buy
1,000
+300
+43% +$8.49K ﹤0.01% 1248
2022
Q4
$19K Hold
700
﹤0.01% 1348
2022
Q3
$16K Sell
700
-700
-50% -$18.7K ﹤0.01% 1405
2022
Q2
$35K Sell
1,400
-500
-26% -$13.8K ﹤0.01% 1442
2022
Q1
$56K Sell
1,900
-400
-17% -$11.7K ﹤0.01% 1336
2021
Q4
$69K Sell
2,300
-300
-12% -$8.94K ﹤0.01% 1332
2021
Q3
$75K Hold
2,600
﹤0.01% 1290
2021
Q2
$75K Hold
2,600
﹤0.01% 1289
2021
Q1
$75K Hold
2,600
﹤0.01% 1427
2020
Q4
$72K Hold
2,600
﹤0.01% 1278
2020
Q3
$49K Hold
2,600
﹤0.01% 1269
2020
Q2
$48K Hold
2,600
﹤0.01% 1234
2020
Q1
$40K Hold
2,600
﹤0.01% 1216
2019
Q4
$60K Sell
2,600
-200
-7% -$4.55K ﹤0.01% 1168
2019
Q3
$61K Hold
2,800
﹤0.01% 1092
2019
Q2
$61K Hold
2,800
﹤0.01% 1099
2019
Q1
$59K Hold
2,800
﹤0.01% 1069
2018
Q4
$51K Hold
2,800
﹤0.01% 1093
2018
Q3
$62K Hold
2,800
﹤0.01% 1076
2018
Q2
$61K Buy
+2,800
New +$60.9K ﹤0.01% 962

Other funds holding FSCS

Geneos Wealth Management's FSCS Position: Q3 2025 in Review

Geneos Wealth Management sold out of First Trust SMID Capital Strength ETF (FSCS) in Q3 2025, closing a stake of 600 shares — an estimated $21.4K sold.

Geneos Wealth Management first reported a position in FSCS in Q2 2018 and held it in 29 quarters. The position peaked at $114K in Q1 2025. 32 funds tracked by Wall St. Rank hold FSCS as of Q3 2025.

  • Geneos Wealth Management reported no remaining First Trust SMID Capital Strength ETF position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 600 First Trust SMID Capital Strength ETF shares in Q3 2025, an estimated $21.4K.
  • Geneos Wealth Management first reported a position in First Trust SMID Capital Strength ETF in Q2 2018 and held it in 29 quarters.
  • Geneos Wealth Management's First Trust SMID Capital Strength ETF position peaked at $114K in Q1 2025.
  • 32 funds tracked by Wall St. Rank held First Trust SMID Capital Strength ETF as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.